M Mrsic
Overview
Explore the profile of M Mrsic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aurer I, Mitrovic Z, Nemet D, Radman I, Sertic D, Serventi-Seiwerth R, et al.
J Chemother
. 2008 Dec;
20(5):640-4.
PMID: 19048695
We report the outcomes of 45 patients with relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL) treated with a combination of ifosfamide, carboplatinum and etoposide (ICE) and 28 patients treated with...
2.
Golubic-Cepulic B, Budimir A, Plecko V, Plenkovic F, Mrsic M, Sarlija D, et al.
Transfus Med
. 2004 Jun;
14(3):237-40.
PMID: 15180816
Bacterial contamination of blood products causes significant patient morbidity and mortality. Contaminated platelet transfusion is a frequent cause of bacteraemia and sepsis because of the storage conditions of platelets. A...
3.
Labar B, Rudan I, Ivankovic D, Biloglav Z, Mrsic M, Strnad M, et al.
Eur J Epidemiol
. 2004 Mar;
19(1):55-60.
PMID: 15012023
Some of potential causes proposed to explain the reported increase of haematological malignancies in childhood during or after the war period in several countries include depleted uranium, chemical pollution and...
4.
Radman I, Basic N, Labar B, Kovacevic J, Aurer I, Bogdanic V, et al.
Ann Oncol
. 2002 Oct;
13(10):1650-5.
PMID: 12377656
Background: The aim of this study was to analyze outcome of patients with Hodgkin's disease (HD) in whom first-line chemotherapy with mustine/vincristine/procarbazine/prednisone (MOPP) had failed. Patients And Methods: From January...
5.
Mihaljevic-Peles A, Jakovljevic M, Mrsic M, Sagud M
Nord J Psychiatry
. 2002 Feb;
55(6):449-50.
PMID: 11859840
No abstract available.
6.
Mrsic M, Grgic M, Budisic Z, Podolski P, Bogdanic V, Labar B, et al.
Ann Oncol
. 2001 Aug;
12 Suppl 1:S95-6.
PMID: 11521730
A significant number of women with advanced breast cancer fail to respond to standard-dose chemotherapy. From the beginning of 1999, 17 women with HER2 positive advanced breast cancer received Herceptin...
7.
Sucic M, Boban D, Markovic-Glamocak M, Bogdanic V, Nemet D, Labar B, et al.
Ren Fail
. 1998 Aug;
20(4):613-20.
PMID: 9713880
The aim of the study was to determine the relationship, if any, between abnormalities in urinary cytology and the administration of cyclosporine A in bone marrow transplant recipients. Specific attention...
8.
Bogdanic V, Aurer I, Labar B, Hitrec V, Nemet D, Mrsic M
Haematologica
. 1998 Jul;
83(6):575-6.
PMID: 9676036
Umbilical cord blood (UCB) is increasingly used as a source of hematopoietic progenitor cells for allotransplantation. Donor-derived buffy coat cells are considered optimal treatment for leukemia relapses after transplantation of...
9.
Gregurek R, Labar B, Mrsic M, Batinic D, Ladika I, Bogdanic V, et al.
Bone Marrow Transplant
. 1996 Sep;
18(3):585-9.
PMID: 8879622
In order to determine the influence of anxiety on the development of BMT complications and survival, we analysed data on 35 consecutive patients undergoing BMT in our Centre between June...
10.
Labar B, Masszi T, Morabito F, Mistrik M, Holowiecki J, Bogdanic V, et al.
Bone Marrow Transplant
. 1996 Jun;
17(6):1009-12.
PMID: 8807107
From October 1984 to December 1994, 142 patients from six IGCI-BMT centers (78 acute myelogenous leukemia and 64 acute lymphoblastic leukemia) received allogeneic bone marrow from their HLA-identical sibling. The...